Stockreport

FDA greenlights Regeneron's Dupixent for the treatment of COPD [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Pharmaceuticals and Sanofi have expanded the US label of Dupixent (dupilumab) to treat chronic obstructive pulmonary disease (COPD). The approval makes COPD the sixth in [Read more]